Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD-Reference-Cited by-同舟云学术

Personalized prediction of adverse heart and kidney events using baseline and longitudinal data from SPRINT and ACCORD

Published:2019-08-08 Issue:8 Volume:14 Page:e0219728
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Dinstag Gal,Amar David,Ingelsson Erik^ORCID,Ashley Euan,Shamir Ron^ORCID

Funder

ISF-NSFC

ISF

Len Blavatnik and the Blavatnik Family foundation

Edmond J. Safra Center for Bioinformatics at Tel Aviv University

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference17 articles.

1. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH / ASPC / NMA / PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults;PK Whelton;Hypertension,2017

2. Diagnosis and treatment of hypertension in the 2017 ACC/AHA guidelines and in the real world;JPA Ioannidis;J Am Med Assoc,2018

3. A randomized trial of intensive versus standard blood-pressure control;N Engl J Med,2016

4. Learning What We Didn’t Know—The SPRINT Data Analysis Challenge;NS Burns;N Engl J Med,2017

5. Systolic blood pressure response in SPRINT (Systolic Blood Pressure Intervention Trial) and ACCORD (Action to Control Cardiovascular Risk in Diabetes): A possible explanation for discordant trial results;C Huang;J Am Heart Assoc,2017

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility of Precision Medicine in Hypertension Management—Scope and Technological Aspects;Journal of Personalized Medicine;2022-11-07

2. Can Machine Learning from Real-World Data Support Drug Treatment Decisions? A Prediction Modeling Case for Direct Oral Anticoagulants;Medical Decision Making;2021-12-15

3. Nomogram to predict risk of incident chronic kidney disease in high-risk population of cardiovascular disease in China: community-based cohort study;BMJ Open;2021-11

Using the Causal Inference Framework to Support Individualized Drug Treatment Decisions Based on Observational Healthcare Data

;Clinical Epidemiology;2020-11